Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leukemia

Showing results (291-300 of 13,978) with videos related to

Pageof 1,398
Sort By:
Leukemia|May 1, 1990
IL-3 inhibits the binding of GM-CSF to AML blasts, but the two cytokines act synergistically in supporting blast proliferationN Onetto-Pothier, N Aumont, A Haman, et al.
Leukemia|May 1, 1990
The effect of cytokines, including IL-1, IL-4, and IL-6, in hairy cell proliferation/differentiationS D Griffiths, J C Cawley
Leukemia|May 1, 1990
Blast crisis accompanied with occurrence of the point-mutational activation of N-ras proto-oncogene and the chromosomal abnormality inv(3q) in chronic myelogenous leukemia presenting thrombocytosisM Okabe, Y Kunieda, I Saiki, et al.
Leukemia|August 1, 1990
Effects of rhGM-CSF on intracellular ara-C pharmacology in vitro in acute myelocytic leukemia: comparability with drug-induced humoral stimulatory activityJ E Karp, P J Burke, R C Donehower
Leukemia|August 1, 1990
Hemopoietin-1 activity of interleukin-1 (IL-1) on acute myeloid leukemia colony-forming cells (AML-CFU) in vitro: IL-1 induces production of tumor necrosis factor-alpha which synergizes with IL-3 or granulocyte-macrophage colony-stimulating factorR Delwel, C van Buitenen, M Salem, et al.
Leukemia|October 1, 2011
Long-term transfusion independence in del(5q) MDS patients who discontinue lenalidomideA A N Giagounidis, A Kulasekararaj, U Germing, et al.
Leukemia|October 19, 2011
Bisphosphonates as antimyeloma drugsN D Modi, S Lentzsch
Leukemia|October 19, 2011
Short telomeres result in chromosomal instability in hematopoietic cells and precede malignant evolution in human aplastic anemiaR T Calado, J N Cooper, H M Padilla-Nash, et al.
Leukemia|April 18, 2012
Primary plasma cell leukemia: clinical and laboratory presentation, gene-expression profiling and clinical outcome with Total Therapy protocolsS Z Usmani, B Nair, P Qu, et al.
Leukemia|December 1, 1990
Isotype switch and idiotype variation in hairy cell leukemiaC Heirman, E Vaeremans, D Carels, et al.
Pageof 1,398

Showing results (291-300 of 13,978) with videos related to

Sort By:
Pageof 1,398
Leukemia|May 1, 1990
IL-3 inhibits the binding of GM-CSF to AML blasts, but the two cytokines act synergistically in supporting blast proliferationN Onetto-Pothier, N Aumont, A Haman, et al.
Leukemia|May 1, 1990
The effect of cytokines, including IL-1, IL-4, and IL-6, in hairy cell proliferation/differentiationS D Griffiths, J C Cawley
Leukemia|May 1, 1990
Blast crisis accompanied with occurrence of the point-mutational activation of N-ras proto-oncogene and the chromosomal abnormality inv(3q) in chronic myelogenous leukemia presenting thrombocytosisM Okabe, Y Kunieda, I Saiki, et al.
Leukemia|August 1, 1990
Effects of rhGM-CSF on intracellular ara-C pharmacology in vitro in acute myelocytic leukemia: comparability with drug-induced humoral stimulatory activityJ E Karp, P J Burke, R C Donehower
Leukemia|August 1, 1990
Hemopoietin-1 activity of interleukin-1 (IL-1) on acute myeloid leukemia colony-forming cells (AML-CFU) in vitro: IL-1 induces production of tumor necrosis factor-alpha which synergizes with IL-3 or granulocyte-macrophage colony-stimulating factorR Delwel, C van Buitenen, M Salem, et al.
Leukemia|October 1, 2011
Long-term transfusion independence in del(5q) MDS patients who discontinue lenalidomideA A N Giagounidis, A Kulasekararaj, U Germing, et al.
Leukemia|October 19, 2011
Bisphosphonates as antimyeloma drugsN D Modi, S Lentzsch
Leukemia|October 19, 2011
Short telomeres result in chromosomal instability in hematopoietic cells and precede malignant evolution in human aplastic anemiaR T Calado, J N Cooper, H M Padilla-Nash, et al.
Leukemia|April 18, 2012
Primary plasma cell leukemia: clinical and laboratory presentation, gene-expression profiling and clinical outcome with Total Therapy protocolsS Z Usmani, B Nair, P Qu, et al.
Leukemia|December 1, 1990
Isotype switch and idiotype variation in hairy cell leukemiaC Heirman, E Vaeremans, D Carels, et al.
Pageof 1,398